Literature DB >> 22814806

Rituximab in IgG4-related inflammatory disease of the orbit and ocular adnexae.

D Lindfield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22814806      PMCID： PMC3470046          DOI： 10.1038/eye.2012.147

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  6 in total

Review 1.  IgG4-related systemic disease as a cause of "idiopathic" orbital inflammation, including orbital myositis, and trigeminal nerve involvement.

Authors:  Zachary S Wallace; Arezou Khosroshahi; Frederick A Jakobiec; Vikram Deshpande; Mark P Hatton; Jill Ritter; Judith A Ferry; John H Stone
Journal:  Surv Ophthalmol       Date:  2011-10-21       Impact factor: 6.048

Review 2.  A clinical overview of IgG4-related systemic disease.

Authors:  Arezou Khosroshahi; John H Stone
Journal:  Curr Opin Rheumatol       Date:  2011-01       Impact factor: 5.006

Review 3.  Systemic immunoglobulin G4 (IgG4) disease and idiopathic orbital inflammation; removing 'idiopathic' from the nomenclature?

Authors:  D Lindfield; K Attfield; A McElvanney
Journal:  Eye (Lond)       Date:  2012-02-03       Impact factor: 3.775

4.  Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients.

Authors:  Arezou Khosroshahi; Mollie N Carruthers; Vikram Deshpande; Sebastian Unizony; Donald B Bloch; John H Stone
Journal:  Medicine (Baltimore)       Date:  2012-01       Impact factor: 1.889

5.  Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.

Authors:  Simon R J Taylor; Alan D Salama; Lavnish Joshi; Charles D Pusey; Susan L Lightman
Journal:  Arthritis Rheum       Date:  2009-05

Review 6.  Diagnosis and management of orbital pseudotumor.

Authors:  Dina Jacobs; Steven Galetta
Journal:  Curr Opin Ophthalmol       Date:  2002-12       Impact factor: 3.761
  6 in total
  2 in total

1.  Ophthalmic manifestations in IgG4-related disease: Clinical presentation and response to treatment in a French case-series.

Authors:  Mikael Ebbo; Matthieu Patient; Aurelie Grados; Matthieu Groh; Julien Desblaches; Eric Hachulla; David Saadoun; Sylvain Audia; Aude Rigolet; Benjamin Terrier; Antoinette Perlat; Constance Guillaud; Frederic Renou; Emmanuelle Bernit; Nathalie Costedoat-Chalumeau; Jean-Robert Harlé; Nicolas Schleinitz
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

2.  IgG4-Related Dacryoadenitis in Egyptian Patients: A Retrospective Study.

Authors:  Omar Hassan Salama; Ezzat Nabil Abbas Ibrahim; Mostafa Osman Hussein; Ahmed Mohammed Madinah Alkady; Mohammed Eid Abd El-Salam; Saad Ghanem
Journal:  Clin Ophthalmol       Date:  2022-08-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.